Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eitan Raveh

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 8, 2023
Oculometric measures as a tool for assessment of clinical symptoms and severity of Parkinson's diseaseJohnathan Reiner, Liron Franken, Eitan Raveh, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 8, 2024
Changes in saccadic intrusions over time as an objective biomarker to follow ALS disease progressionOmer Berkman, Eitan Raveh, Eran Harpaz, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 7, 2023
Correlation between oculometric measures and clinical assessment in ALS patients participating in a phase IIb clinical drug trialEitan Raveh, Assaf Ben-Shimon, Vova Anisimov, et al.
Pharmaceutical Medicine|May 30, 2026
Changes in Saccadic Hypometria over Time to Monitor Parkinson's Disease ProgressionEdmund Ben-Ami, Eitan Raveh, Eran Harpaz, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 8, 2023
Oculometric measures as a tool for assessment of clinical symptoms and severity of Parkinson's diseaseJohnathan Reiner, Liron Franken, Eitan Raveh, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 8, 2024
Changes in saccadic intrusions over time as an objective biomarker to follow ALS disease progressionOmer Berkman, Eitan Raveh, Eran Harpaz, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 7, 2023
Correlation between oculometric measures and clinical assessment in ALS patients participating in a phase IIb clinical drug trialEitan Raveh, Assaf Ben-Shimon, Vova Anisimov, et al.
Pharmaceutical Medicine|May 30, 2026
Changes in Saccadic Hypometria over Time to Monitor Parkinson's Disease ProgressionEdmund Ben-Ami, Eitan Raveh, Eran Harpaz, et al.
Pageof 2